Comparison of CSF biomarker levels related to pathogenesis between PD patients and controls or other neurodegenerative diseases

Training and validation set indicate the cohort to discover biomarkers and independently validate these, respectively.

Abbreviations: HC, healthy controls; PDD, PD dementia; DLB, dementia with Lewy bodies, PD-CI, PD with cognitive impairment; MCI, mild cognitive impairment; t-protein, total protein in CSF; UA, uric acid; XAN, xanthine; HVA, homovallinic acid.

Exp Neurobiol 2014;23:352~364
© Exp Neurobiol